RecruitingNCT02431845
Biological factors linked to SSRI response in OCD
About this title
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder
Read the official source — NCT02431845Medication studyAges 19–70South Korea
Understand this study
Who could participate?
Listed age limits: 19 years to 70 years.
- Listed locations
- SeoulSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 1, 2013
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- Severance Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- South Korea
- Age range
- From 19 Years to 70 Years
- Official registry ID
- NCT02431845
- Official title
Show the full official title
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Seoul
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Severance Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including SSRIs.
Who can participate?
Listed age limits: 19 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
